Research / ANGI / Fundamental state Inspectable configuration
State dimensions Filing 0001705110-21-000121 General Corporate
Debt relative to revenue 80th Own-history percentile · N=15
Evidence method Level · gp.fundamentals.debt_to_revenue
107.11% · OPTIONAL · VALID
Capex intensity 20th Own-history percentile · N=15
Evidence method Level · gp.fundamentals.capex_revenue_ratio
3.54% · OPTIONAL · VALID
Operating cash generation 0th Own-history percentile · N=14
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-7.23% · OPTIONAL · VALID
Revenue growth 82th Own-history percentile · N=11
Evidence method Yoy · gp.fundamentals.revenue
18.38% · CORE · VALID
Operating margin 27th Own-history percentile · N=15
Evidence method Level · gp.fundamentals.operating_margin
-3.24% · CORE · VALID
R&D intensity 0th Own-history percentile · N=15
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
3.83% · OPTIONAL · VALID
SBC intensity 7th Own-history percentile · N=15
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
1.91% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 31 states Self-history eligible
Sep 30, 2021 7/7 normalized Level 3 Dec 31, 2021 6/6 normalized Level 3 Mar 31, 2022 6/6 normalized Level 3 Jun 30, 2022 6/7 normalized Level 3 Sep 30, 2022 6/7 normalized Level 3 Dec 31, 2022 6/7 normalized Level 3 Mar 31, 2023 6/7 normalized Level 3 Jun 30, 2023 6/7 normalized Level 3 Sep 30, 2023 6/7 normalized Level 3 Dec 31, 2023 5/6 normalized Level 3 Mar 31, 2024 5/6 normalized Level 3 Jun 30, 2024 6/6 normalized Level 3 Sep 30, 2024 6/6 normalized Level 3 Dec 31, 2024 6/6 normalized Level 3 Mar 31, 2025 7/7 normalized Level 3 Jun 30, 2025 7/7 normalized Level 3 Sep 30, 2025 7/7 normalized Level 3 Dec 31, 2025 6/6 normalized Level 3 Mar 31, 2026 7/7 normalized Level 3 Jun 30, 2026 7/7 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 117.39%
Current 107.11%
Delta -10.28% Capex Intensity Decreased
Previous 4.03%
Current 3.54%
Delta -0.49% Cash Generation Decreased
Previous 10.43%
Current -7.23%
Delta -17.66% Growth Increased
Previous 12.25%
Current 18.38%
Delta 6.13% Profitability Increased
Previous -7.77%
Current -3.24%
Delta 4.53% R And D Intensity Decreased
Previous 4.45%
Current 3.83%
Delta -0.62% Sbc Intensity Decreased
Previous 2.27%
Current 1.91%
Delta -0.36% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.